Publicações

Benefits and Risks of Adjuvant Treatment with Zoledronic Acid in Stage Ii/Iii Breast Cancer. 10 Years Follow-Up of the Azure Randomized Clinical Trial (Big 01/04)

AuthID
P-00P-RDT

Author(s)

Coleman, RE

Collinson, M

Gregory, W

Marshall, H

Bell, R

Dodwell, D

Keane, M

Gil, M

Barrett Lee, P

Ritchie, D

[+3]·

Passos Coelho, JL

O'Reilly, S

Bertelli, G

Joffe, J

Brown, JE

Wilson, C

Tercero, JC

Jean Mairet, J

Gomis, R

Cameron, D

View all authors

Tipo de Documento

Article

Year published

2018

Publicado

in JOURNAL OF BONE ONCOLOGY, ISSN: 2212-1374

Volume: 13, Páginas: 123-135 (13)

Indexing

Wos^®

Scopus^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1016/j.jbo.2018.09.008

SCOPUS: 2-s2.0-85054721998

Wos: WOS:000450344400011

Source Identifiers

ISSN: 2212-1374

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Nome	Name Order	Nome	Name Order	Nome
1	Coleman, RE;	2	Collinson, M;	3	Gregory, W;
4	Marshall, H;	5	Bell, R;	6	Dodwell, D;
7	Keane, M;	8	Gil, M;	9	Barrett Lee, P;
10	Ritchie, D;	11	Bowman, A;	12	Liversedge, V;
13	De Boer, RH;	14	Passos Coelho, JL;	15	O'Reilly, S;
16	Bertelli, G;	17	Joffe, J;	18	Brown, JE;
19	Wilson, C;	20	Tercero, JC;	21	Jean Mairet, J;
22	Gomis, R;	23	Cameron, D;

Benefits and Risks of Adjuvant Treatment with Zoledronic Acid in Stage Ii/Iii Breast Cancer. 10 Years Follow-Up of the Azure Randomized Clinical Trial (Big 01/04)

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Benefits and Risks of Adjuvant Treatment with Zoledronic Acid in Stage Ii/Iii Breast Cancer. 10 Years Follow-Up of the Azure Randomized Clinical Trial (Big 01/04)

Links Úteis

Ajuda